about
Mindfulness Intervention for Stress Eating to Reduce Cortisol and Abdominal Fat among Overweight and Obese Women: An Exploratory Randomized Controlled StudyT cell responses to human endogenous retroviruses in HIV-1 infectionMicrobial translocation is a cause of systemic immune activation in chronic HIV infectionTIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV InfectionNew DNA viruses identified in patients with acute viral infection syndrome.Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infectionChanges in stress, eating, and metabolic factors are related to changes in telomerase activity in a randomized mindfulness intervention pilot studyTransmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionThe major genetic determinants of HIV-1 control affect HLA class I peptide presentation.Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory.Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.Feasibility and Preliminary Efficacy of a Novel RDoC-Based Treatment Program for Adolescent Depression: "Training for Awareness Resilience and Action" (TARA)-A Pilot Study.Improving Assessment of the Spectrum of Reward-Related Eating: The RED-13.Effects of a mindfulness-based intervention on mindful eating, sweets consumption, and fasting glucose levels in obese adults: data from the SHINE randomized controlled trial.Reduced reward-driven eating accounts for the impact of a mindfulness-based diet and exercise intervention on weight loss: Data from the SHINE randomized controlled trial.Impact of a Mindfulness-Based Weight-Loss Intervention on Sleep Quality Among Adults with Obesity: Data from the SHINE Randomized Controlled Trial.Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus.High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replicationCytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease.Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.Correlating traditional Ayurvedic and modern medical perspectives on cancer: results of a qualitative studyHIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.Predominance of weakly cytotoxic, T-betLowEomesNeg CD8+ T-cells in human gastrointestinal mucosa: implications for HIV infection.Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individualsFunctional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progressionImmune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruptionImmune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.A yoga intervention for type 2 diabetes risk reduction: a pilot randomized controlled trial.Enriched environment and stress exposure influence splenic B lymphocyte composition.HIV RNA level in early infection is predicted by viral load in the transmission source.Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.Use of laboratory tests and clinical symptoms for identification of primary HIV infection.Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade.The development of an RDoC-based treatment program for adolescent depression: "Training for Awareness, Resilience, and Action" (TARA)
P50
Q21296762-300BA98A-FF07-40E7-A6A6-C016C48D60C7Q21559508-8F7ED991-FFD6-48AF-85B7-2DDAD2E5B508Q22251054-6177A047-BB51-4CCD-BF70-39A9A325C676Q27316403-3108E189-760A-474B-A3A4-D2ABC993C1B6Q27469839-BC5AC335-D5DA-4DDE-8A71-91127665BED7Q27486378-AA3E22C1-685C-4F39-ADE7-234203B5D086Q28385790-4350B21C-34C0-413E-8F17-FA7065434B3CQ28476489-D22325A6-994E-4D1F-BFA8-0ADE08E0B108Q28480902-4CE6BEFB-246E-4480-9AA6-39F677520A17Q29417018-49667B36-95A4-4B60-A2E0-AD8DEB61121BQ30478483-E3DE5184-3225-4068-AAAE-5ACCD7916824Q30596338-862B6412-262D-4BEB-B616-265C5ECD847FQ30835050-ABA4CCED-E445-4C22-B872-95E4E5F71932Q30853887-CFA9B252-B15F-4333-82EE-BFFD2F7A16A7Q31022442-84A51A0C-DCB9-4230-B09E-880629089D8EQ31044371-ACA0AA9A-6210-4360-90AF-E4DC90EAF323Q31151796-03142982-2B22-4027-BFB1-2DC5D5C243D6Q33274640-3E8F30CB-2522-4B09-91E5-D413B160276CQ33379075-915847BE-9D75-4603-9D25-208063BA9C87Q33406497-A675152F-AF59-4EFF-94ED-06F2A026C719Q33528999-9AC87AD8-ACB2-4D20-8031-63C3C7AAE9C3Q33565727-CCAA9BF7-8AE7-47D6-AB93-03D770B3A337Q33571710-8F774475-367C-4DE8-85BF-C86ADE0AB1E1Q33614208-CFC959E9-A964-4318-B8D6-222440C9F666Q33618542-5F6D4A08-60C7-4A16-BE6A-BE7CAAA88CC0Q33653526-6E1FA83E-E905-45CC-A42C-34CC12AC4C8FQ33685141-62BC1552-DA3C-4D21-8BBF-698E494223C0Q33712891-3C44B718-D1F7-4890-AC65-5FE229DB3A71Q33745356-0F488569-9F40-4910-8277-4668949529BDQ33772422-803321FF-E7A2-4622-ADC0-9EB71FEE0A40Q33776495-80583973-3389-4773-9958-2524E20F76FBQ33786292-A27F963B-60EF-42C1-94E2-B712E7DC42F0Q33895265-EE99EABD-2D7B-45EA-8ABA-D13161A6D1B8Q33898547-B9A8A3A1-C7C9-4AE1-BDD8-2F8E5AF2E403Q33921382-1478C533-51A9-4B14-B7C6-749FD87BB1CCQ33947817-F72AD9A0-E9BA-4BDE-ACBE-AFB957AAF2FAQ33959065-596A5B7B-6F2E-45B0-83A2-578044EFF445Q33991362-82E834EA-CA6C-4ACE-88AD-DEF4F29A6A50Q34018322-D613728E-683D-4BF6-8E4A-E92AF9C32B4CQ34063322-4C154141-7AFA-434F-A7E0-CF298DFDE84D
P50
description
biomedical researcher
@en
wetenschapper
@nl
name
Frederick M. Hecht
@ast
Frederick M. Hecht
@en
Frederick M. Hecht
@es
Frederick M. Hecht
@nl
Frederick M. Hecht
@sl
فريدريك إم. هيكت
@ar
type
label
Frederick M. Hecht
@ast
Frederick M. Hecht
@en
Frederick M. Hecht
@es
Frederick M. Hecht
@nl
Frederick M. Hecht
@sl
فريدريك إم. هيكت
@ar
altLabel
Rick Hecht
@en
prefLabel
Frederick M. Hecht
@ast
Frederick M. Hecht
@en
Frederick M. Hecht
@es
Frederick M. Hecht
@nl
Frederick M. Hecht
@sl
فريدريك إم. هيكت
@ar
P214
P244
P106
P1153
7103064306
P1960
BapD9LwAAAAJ
P21
P214
P244
P31
P496
0000-0002-5782-1171
P734
P735
P7859
lccn-n89138631